What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Cell adhesion molecule, Immunology, Cell biology, Cancer research and Cell adhesion.
His studies deal with areas such as Fibronectin, Molecular biology, CD31, Integrin and Cell–cell interaction as well as Cell adhesion molecule.
His research investigates the connection between Integrin and topics such as Extracellular matrix that intersect with problems in Pathology, Wound healing and Cancer cell.
As a part of the same scientific family, Steven M. Albelda mostly works in the field of Immunology, focusing on Myeloid-derived Suppressor Cell and, on occasion, Structural gene, Respiratory burst and Cell type.
The Cell biology study combines topics in areas such as Endothelial stem cell, Biochemistry, Neural cell adhesion molecule and In vivo.
His research in Cancer research intersects with topics in Cytotoxic T cell, Interleukin 21, Thymidine kinase and Tumor progression.
His most cited work include:
- Integrins and other cell adhesion molecules. (1723 citations)
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN (1592 citations)
- BRAF and RAS mutations in human lung cancer and melanoma (949 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cancer research, Immunology, Cell biology, Pathology and Cell adhesion molecule.
Steven M. Albelda has included themes like Mesothelioma, CD8, Genetic enhancement, Lung cancer and In vivo in his Cancer research study.
His Immunology study frequently draws connections between related disciplines such as Cytotoxic T cell.
As a part of the same scientific study, Steven M. Albelda usually deals with the Cell biology, concentrating on Endothelial stem cell and frequently concerns with Endothelium.
His Pathology research is multidisciplinary, incorporating elements of Respiratory disease, Lung injury and Lung.
His Cell adhesion molecule research also works with subjects such as
- Cell adhesion which connect with Cell–cell interaction,
- Integrin, which have a strong connection to Fibronectin.
He most often published in these fields:
- Cancer research (29.54%)
- Immunology (25.53%)
- Cell biology (18.35%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (29.54%)
- Immunotherapy (13.92%)
- T cell (10.55%)
In recent papers he was focusing on the following fields of study:
Steven M. Albelda mainly focuses on Cancer research, Immunotherapy, T cell, Immunology and Chimeric antigen receptor.
His Cancer research research includes themes of Cancer, CD8, Antigen, Flow cytometry and In vivo.
Steven M. Albelda combines subjects such as Mesothelin, Mesothelioma and Lung cancer, Oncology with his study of Immunotherapy.
His biological study spans a wide range of topics, including Tumor microenvironment, Cytotoxic T cell, Antibody and Molecular biology.
His study brings together the fields of Vector and Immunology.
His Chimeric antigen receptor study combines topics in areas such as Receptor, Adoptive cell transfer, Cell therapy, CD19 and Cell biology.
Between 2013 and 2021, his most popular works were:
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies (496 citations)
- CAR T Cell Therapy for Solid Tumors. (296 citations)
- Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. (278 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Steven M. Albelda spends much of his time researching Cancer research, Immunotherapy, Immunology, T cell and Antigen.
His Cancer research research incorporates elements of Cell, Immune system, FOXP3, Chimeric antigen receptor and Flow cytometry.
His work deals with themes such as Cytotoxic T cell, Antibody and CD8, which intersect with Immunotherapy.
Within one scientific family, Steven M. Albelda focuses on topics pertaining to T-cell receptor under Cytotoxic T cell, and may sometimes address concerns connected to Biochemistry and Cell biology.
His Immunology research includes themes of Receptor and Cancer development.
His T cell research is multidisciplinary, incorporating perspectives in Cell signaling, Chemokine receptor, CXCR3 and Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
